 | • レポートコード：QYR9N7891 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、前立腺がんバイオマーカーのグローバル市場について調査・分析したレポートで、種類別（尿、血液、血清）、用途別（病院、診療所、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・前立腺がんバイオマーカーの世界市場規模 ・主要企業別市場シェア ・前立腺がんバイオマーカーの世界市場規模：種類別（尿、血液、血清） ・前立腺がんバイオマーカーの世界市場規模：用途別（病院、診療所、がん研究所） ・前立腺がんバイオマーカーのアメリカ市場規模（種類別、用途別） ・前立腺がんバイオマーカーのヨーロッパ市場規模（種類別、用途別） ・前立腺がんバイオマーカーの中国市場規模（種類別、用途別） ・前立腺がんバイオマーカーの日本市場規模（種類別、用途別） ・前立腺がんバイオマーカーの東南アジア市場規模（種類別、用途別） ・前立腺がんバイオマーカーのインド市場規模（種類別、用途別） ・前立腺がんバイオマーカーの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・前立腺がんバイオマーカーの世界市場予測（2019年-2025年） ・前立腺がんバイオマーカーの地域別市場予測（2019年-2025年） ... |
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.
In 2018, the global Prostate Cancer Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prostate Cancer Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Biomarker development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
Market segment by Type, the product can be split into
Urine
Blood
Serum
Market segment by Application, split into
Hospitals
Clinics
Cancer Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Prostate Cancer Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Biomarker development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prostate Cancer Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type (2014-2025)
1.4.2 Urine
1.4.3 Blood
1.4.4 Serum
1.5 Market by Application
1.5.1 Global Prostate Cancer Biomarker Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Prostate Cancer Biomarker Market Size
2.2 Prostate Cancer Biomarker Growth Trends by Regions
2.2.1 Prostate Cancer Biomarker Market Size by Regions (2014-2025)
2.2.2 Prostate Cancer Biomarker Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Prostate Cancer Biomarker Market Size by Manufacturers
3.1.1 Global Prostate Cancer Biomarker Revenue by Manufacturers (2014-2019)
3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Biomarker Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Biomarker Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Biomarker Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Biomarker Market Size by Type (2014-2019)
4.2 Global Prostate Cancer Biomarker Market Size by Application (2014-2019)
5 United States
5.1 United States Prostate Cancer Biomarker Market Size (2014-2019)
5.2 Prostate Cancer Biomarker Key Players in United States
5.3 United States Prostate Cancer Biomarker Market Size by Type
5.4 United States Prostate Cancer Biomarker Market Size by Application
6 Europe
6.1 Europe Prostate Cancer Biomarker Market Size (2014-2019)
6.2 Prostate Cancer Biomarker Key Players in Europe
6.3 Europe Prostate Cancer Biomarker Market Size by Type
6.4 Europe Prostate Cancer Biomarker Market Size by Application
7 China
7.1 China Prostate Cancer Biomarker Market Size (2014-2019)
7.2 Prostate Cancer Biomarker Key Players in China
7.3 China Prostate Cancer Biomarker Market Size by Type
7.4 China Prostate Cancer Biomarker Market Size by Application
8 Japan
8.1 Japan Prostate Cancer Biomarker Market Size (2014-2019)
8.2 Prostate Cancer Biomarker Key Players in Japan
8.3 Japan Prostate Cancer Biomarker Market Size by Type
8.4 Japan Prostate Cancer Biomarker Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Biomarker Market Size (2014-2019)
9.2 Prostate Cancer Biomarker Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Biomarker Market Size by Type
9.4 Southeast Asia Prostate Cancer Biomarker Market Size by Application
10 India
10.1 India Prostate Cancer Biomarker Market Size (2014-2019)
10.2 Prostate Cancer Biomarker Key Players in India
10.3 India Prostate Cancer Biomarker Market Size by Type
10.4 India Prostate Cancer Biomarker Market Size by Application
11 Central & South America
11.1 Central & South America Prostate Cancer Biomarker Market Size (2014-2019)
11.2 Prostate Cancer Biomarker Key Players in Central & South America
11.3 Central & South America Prostate Cancer Biomarker Market Size by Type
11.4 Central & South America Prostate Cancer Biomarker Market Size by Application
12 International Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Biomarker Introduction
12.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 QIAGEN
12.2.1 QIAGEN Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Biomarker Introduction
12.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.2.5 QIAGEN Recent Development
12.3 Roche Diagnostics
12.3.1 Roche Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Biomarker Introduction
12.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.3.5 Roche Diagnostics Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Biomarker Introduction
12.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.4.5 Beckman Coulter Recent Development
12.5 Myriad Genetics
12.5.1 Myriad Genetics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Biomarker Introduction
12.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.5.5 Myriad Genetics Recent Development
12.6 Sanofi-Aventis
12.6.1 Sanofi-Aventis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Biomarker Introduction
12.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.6.5 Sanofi-Aventis Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Biomarker Introduction
12.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 MDx Health
12.8.1 MDx Health Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Biomarker Introduction
12.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2014-2019)
12.8.5 MDx Health Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Prostate Cancer Biomarker Key Market Segments
Table Key Players Prostate Cancer Biomarker Covered
Table Global Prostate Cancer Biomarker Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Prostate Cancer Biomarker Market Size Market Share by Type 2014-2025
Figure Urine Figures
Table Key Players of Urine
Figure Blood Figures
Table Key Players of Blood
Figure Serum Figures
Table Key Players of Serum
Table Global Prostate Cancer Biomarker Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Cancer Institutes Case Studies
Figure Prostate Cancer Biomarker Report Years Considered
Table Global Prostate Cancer Biomarker Market Size 2014-2025 (Million US$)
Figure Global Prostate Cancer Biomarker Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prostate Cancer Biomarker Market Size by Regions 2014-2025 (Million US$)
Table Global Prostate Cancer Biomarker Market Size by Regions 2014-2019 (Million US$)
Table Global Prostate Cancer Biomarker Market Share by Regions 2014-2019
Figure Global Prostate Cancer Biomarker Market Share by Regions 2014-2019
Figure Global Prostate Cancer Biomarker Market Share by Regions 2019
Table Market Top Trends
Table Global Prostate Cancer Biomarker Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Prostate Cancer Biomarker Market Share by Manufacturers (2014-2019)
Figure Global Prostate Cancer Biomarker Market Share by Manufacturers in 2018
Table Global Prostate Cancer Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prostate Cancer Biomarker Product/Solution/Service
Table Date of Enter into Prostate Cancer Biomarker Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table Global Prostate Cancer Biomarker Market Size Share by Type (2014-2019)
Figure Global Prostate Cancer Biomarker Market Size Market Share by Type (2014-2019)
Table Global Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table Global Prostate Cancer Biomarker Market Size Share by Application (2014-2019)
Figure Global Prostate Cancer Biomarker Market Size Market Share by Application (2014-2019)
Figure Global Prostate Cancer Biomarker Revenue Market Share by Application in 2018
Figure United States Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table United States Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table United States Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table United States Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table United States Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table United States Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table United States Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure Europe Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table Europe Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table Europe Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table Europe Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table Europe Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table Europe Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table Europe Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure China Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table China Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table China Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table China Prostate Cancer Biomarker Market Size by Type (2014-20189) (Million US$)
Table China Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table China Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table China Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure Japan Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table Japan Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table Japan Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table Japan Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table Japan Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table Japan Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table Japan Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure Southeast Asia Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table Southeast Asia Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table Southeast Asia Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure India Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table India Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table India Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table India Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table India Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table India Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table India Prostate Cancer Biomarker Market Share by Application (2014-2019)
Figure Central & South America Prostate Cancer Biomarker Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prostate Cancer Biomarker Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prostate Cancer Biomarker Market Share (2018-2019)
Table Central & South America Prostate Cancer Biomarker Market Size by Type (2014-2019) (Million US$)
Table Central & South America Prostate Cancer Biomarker Market Share by Type (2014-2019)
Table Central & South America Prostate Cancer Biomarker Market Size by Application (2014-2019) (Million US$)
Table Central & South America Prostate Cancer Biomarker Market Share by Application (2014-2019)
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2014-2019) (Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table QIAGEN Company Details
Table QIAGEN Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure QIAGEN Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table QIAGEN Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Beckman Coulter Recent Development
Table Myriad Genetics Company Details
Table Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure Myriad Genetics Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Myriad Genetics Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Sanofi-Aventis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table Pfizer Recent Development
Table MDx Health Company Details
Table MDx Health Revenue in Prostate Cancer Biomarker Business (2014-2019)(Million US$)
Figure MDx Health Revenue Growth Rate in Prostate Cancer Biomarker Business (2014-2019)
Table MDx Health Recent Development
Table Global Prostate Cancer Biomarker Market Size by Regions (Million US$) 2019-2025
Figure Global Prostate Cancer Biomarker Market Size Share by Regions (2019-2025)
Figure Global Prostate Cancer Biomarker Market Size Share by Regions in 2025
Figure United States Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure China Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure India Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prostate Cancer Biomarker Market Size Forecast (2019-2025)(Million USD)
Table Global Prostate Cancer Biomarker Market Size by Product (2019-2025) (Million US$)
Figure Global Prostate Cancer Biomarker Market Size by Product (2019-2025)
Figure Global Prostate Cancer Biomarker Market Size by Product in 2025
Table Global Prostate Cancer Biomarker Market Size by Application (2019-2025) (Million US$)
Figure Global Prostate Cancer Biomarker Market Size by Application (2019-2025)
Figure Global Prostate Cancer Biomarker Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …- 世界の前立腺がんのスクリーニング市場：市場規模・現状・予測 Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measur…
- 世界の前立腺がんの診断と治療市場：市場規模・現状・予測 Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. In 2018, t…
- 世界の診断用バイオマーカー市場：市場規模・現状・予測 Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
- 世界の膵がんの診断市場：市場規模・現状・予測 Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…